← Eichor
Study identifier: NCT06443281 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

Condition: Spinal Cord Injuries · Pain, Neuropathic · Nociceptive Pain  ·  Sponsor: University of Zurich

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersYes

About this study

The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.

This description comes directly from the study's public registry record.

Talk to the study team

Michèle Hubli, PD Dr.  ·  +41 44 510 72 03  ·  michele.hubli@balgrist.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Balgrist University HospitalZurich, Canton of Zurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06443281